Ibutamoren Mesylate |
|||
| A3481-100 | ApexBio | 100mg | EUR 542 |
|
Description: Growth hormone (GH) secretagogue |
|||
Ibutamoren Mesylate |
|||
| A3481-25 | ApexBio | 25 mg | EUR 571.2 |
|
Description: Ibutamoren mesylate (MK-0677) is an orally active nonpeptide growth hormone (GH) secretagogue. Ibutamoren mesylate (MK-0677) stimulates GH release through a pituitary and hypothalamic receptor that is different from the GH-releasing hormone receptor. |
|||
Ibutamoren Mesylate |
|||
| A3481-5 | ApexBio | 5 mg | EUR 80 |
|
Description: Growth hormone (GH) secretagogue |
|||
Ibutamoren Mesylate |
|||
| A3481-50 | ApexBio | 50 mg | EUR 345 |
|
Description: Growth hormone (GH) secretagogue |
|||
Ibutamoren mesylate |
|||
| B2400-25 | Biovision | each | EUR 418.8 |
Ibutamoren mesylate |
|||
| B2400-5 | Biovision | each | EUR 157.2 |
Ibutamoren Mesylate |
|||
| T7112-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Ibutamoren Mesylate |
|||
Ibutamoren Mesylate |
|||
| T7112-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Ibutamoren Mesylate |
|||
Ibutamoren Mesylate |
|||
| T7112-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Ibutamoren Mesylate |
|||
Ibutamoren Mesylate |
|||
| T7112-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Ibutamoren Mesylate |
|||
Ibutamoren Mesylate |
|||
| T7112-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Ibutamoren Mesylate |
|||
Ibutamoren (Mesylate) |
|||
| HY-50844 | MedChemExpress | 5mg | EUR 159.6 |
Ibutamoren |
|||
| T20095-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Ibutamoren |
|||
Ibutamoren |
|||
| T20095-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Ibutamoren |
|||
Ibutamoren |
|||
| T20095-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Ibutamoren |
|||
Ibutamoren |
|||
| T20095-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Ibutamoren |
|||
Ibutamoren |
|||
| T20095-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Ibutamoren |
|||
(S)-Carnitine Mesylate, Mesylate Salt |
|||
| C184150 | Toronto Research Chemicals | 100mg | EUR 138 |
|
Description: 161886-60-8 |
|||
Gleevec-d8 Mesylate (Imatinib-d8 Mesylate) |
|||
| G407002 | Toronto Research Chemicals | 0.5mg | EUR 3000 |
|
Description: 1092942-83-0 |
|||
(S)-Carnitine Mesylate Isobutylester, Mesylate Salt |
|||
| C184125 | Toronto Research Chemicals | 10mg | EUR 339 |
PPTN Mesylate |
|||
| T24655-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: PPTN Mesylate |
|||
PPTN Mesylate |
|||
| T24655-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: PPTN Mesylate |
|||
PPTN Mesylate |
|||
| T24655-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: PPTN Mesylate |
|||
PPTN Mesylate |
|||
| T24655-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: PPTN Mesylate |
|||
PPTN Mesylate |
|||
| T24655-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: PPTN Mesylate |
|||
DOTAP Mesylate |
|||
| D535740 | Toronto Research Chemicals | 1g | EUR 1800 |
|
Description: 252769-92-9 |
|||
BM635 mesylate |
|||
| T63263-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: BM635 mesylate |
|||
BM635 mesylate |
|||
| T63263-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: BM635 mesylate |
|||
BM635 mesylate |
|||
| T63263-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: BM635 mesylate |
|||
BM635 mesylate |
|||
| T63263-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: BM635 mesylate |
|||
BM635 mesylate |
|||
| T63263-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: BM635 mesylate |
|||
Oleyl Mesylate |
|||
| T61150-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Oleyl Mesylate |
|||
Oleyl Mesylate |
|||
| T61150-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Oleyl Mesylate |
|||
Oleyl Mesylate |
|||
| T61150-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Oleyl Mesylate |
|||
Oleyl Mesylate |
|||
| T61150-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Oleyl Mesylate |
|||
Oleyl Mesylate |
|||
| T61150-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Oleyl Mesylate |
|||
AC710 (Mesylate) |
|||
| HY-13493A | MedChemExpress | 100mg | EUR 2620.8 |
Oleyl Mesylate |
|||
| O532965 | Toronto Research Chemicals | 5g | EUR 800 |
|
Description: 35709-09-2 |
|||
AC710 Mesylate |
|||
| T10228-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: AC710 Mesylate |
|||
AC710 Mesylate |
|||
| T10228-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: AC710 Mesylate |
|||
AC710 Mesylate |
|||
| T10228-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: AC710 Mesylate |
|||
AC710 Mesylate |
|||
| T10228-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: AC710 Mesylate |
|||
AC710 Mesylate |
|||
| T10228-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: AC710 Mesylate |
|||
AZ7550 Mesylate |
|||
| 471052 | MedKoo Biosciences | 10.0mg | EUR 590 |
AZ7550 Mesylate |
|||
| HY-B0794B | MedChemExpress | 10mg | EUR 666 |
AST2818 (mesylate) |
|||
| HY-112870A | MedChemExpress | 100mg | EUR 3847.2 |
AR-13324 mesylate |
|||
| A253320 | Toronto Research Chemicals | 100mg | EUR 12800 |
|
Description: 1422144-42-0 |
|||
A 80426 mesylate |
|||
| B7025-10 | ApexBio | 10 mg | EUR 244 |
|
Description: α2-adrenoceptor antagonist and 5-HT uptake inhibitor |
|||
A 80426 mesylate |
|||
| B7025-50 | ApexBio | 50 mg | EUR 1026 |
|
Description: α2-adrenoceptor antagonist and 5-HT uptake inhibitor |
|||
(±)-WIN 55,212 (mesylate) |
|||
| T38199-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: (±)-WIN 55,212 (mesylate) |
|||
(±)-WIN 55,212 (mesylate) |
|||
| T38199-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: (±)-WIN 55,212 (mesylate) |
|||
(±)-WIN 55,212 (mesylate) |
|||
| T38199-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: (±)-WIN 55,212 (mesylate) |
|||
(±)-WIN 55,212 (mesylate) |
|||
| T38199-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: (±)-WIN 55,212 (mesylate) |
|||
(±)-WIN 55,212 (mesylate) |
|||
| T38199-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: (±)-WIN 55,212 (mesylate) |
|||
FFN 102 mesylate |
|||
| T41194-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: FFN 102 mesylate |
|||
FFN 102 mesylate |
|||
| T41194-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: FFN 102 mesylate |
|||
FFN 102 mesylate |
|||
| T41194-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: FFN 102 mesylate |
|||
FFN 102 mesylate |
|||
| T41194-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: FFN 102 mesylate |
|||
FFN 102 mesylate |
|||
| T41194-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: FFN 102 mesylate |
|||
Camostat . mesylate |
|||
| 10-017 | ProSci | 50 mg | EUR 410.64 |
|
Description: Camostat is an orally bioavailable trypsin-like protease inhibitor known to inhibit trypsin and various inflammatory proteases including plasmin, kallikrein and thrombin. Camostat has been shown to inhibit the production of TNF-α and monocyte chemoattractant protein-1 by monocytes and to disrupt proliferation of pancreatic stellate cells in a rat model of pancreatic fibrosis. Protease regulation via camostat has also been reported to reversibly inhibit epithelial sodium channel function in human airway epithelial cell models. It is used in the treatment of some forms of cancer and is also effective against some viral infections (such as SARS, MERS or influenza), as well as inhibiting fibrosis in liver or kidney disease or pancreatitis. It suppresses pancreatitis-induced pain in rats following oral administration and is used to treat pancreatitis and reflux esophagitis after gastrectomy. It is an inhibitor of the enzyme transmembrane serine protease TMPRSS2 and partially blocks infection by SARS-CoV and human coronavirus NL63 in HeLa cells and entry of SARS-CoV2 (COVID-19) into lung cells in vitro. |
|||